Level of fatigue in women receiving dose-dense versus standard chemotherapy for breast cancer: A pilot study

Oncology Nursing Forum

Volumn 33, Issue 5, 2006, Pages 1015-1021

  Sura, Wendy ^a   Murphy, Susan O ^b   Gonzales, Irene ^b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAN JOSE STATE UNIVERSITY   (United States)

^c Department of Pediatrics ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CROSS-SECTIONAL STUDY; DOSE RESPONSE; FATIGUE; FEMALE; HUMAN; MIDDLE AGED; NURSING; PATIENT EDUCATION; PROGNOSIS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FATIGUE; FEMALE; HUMANS; MIDDLE AGED; PATIENT EDUCATION; PROGNOSIS;

EID: 33750093592     PISSN: 0190535X     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/06.ONF.1015-1021     Document Type: Article

References (30)

1. American Cancer Society. (2006). Cancer facts and figures 2006. Retrieved July 25, 2006, from http://www.cancer.org/downloads/STT/ CAFF2006PWSecured.pdf
2. Berger, A.M. (1998). Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncology Nursing Forum, 25, 51-62.
3. Berger, A.M., & Higginbotham, P. (2000). Correlates of fatigue during and following adjuvant breast cancer chemotherapy: A pilot study. Oncology Nursing Forum, 27, 1443-1448.
4. Bottomley, A., Therasse, P., Piccart, M., Efficace, F., Coens, C., Gotay, C., et al. (2005). Health-related quality of life in survivors of locally advanced breast cancer: An international randomized controlled phase III trial. Lancet Oncology, 6, 287-294.
5. Bower, J.E., Ganz, P.A., Desmond, K.A., Rowland, J.H., Meyerowitz, B.E., & Belin, T.R. (2000). Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life. Journal of Clinical Oncology, 18, 743-753.
6. Cella, D., Lai, J.S., Chang, C.H., Peterman, A., & Slavin, M. (2002). Fatigue in cancer patients compared with fatigue in the general United States population. Cancer, 94, 528-538.
7. Citron, M.L., Berry, D.A., Cirrincione, C., Hudis, C., Winer, E.P., Gradishar, W.J., et al. (2003). Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of nodes positive primary breast cancer: First report of Intergroup Trial C9741 /Cancer and Leukemia Group B trial 9741. Journal of Clinical Oncology, 21, 1431-1439.
8. Curt, G.A., Breitbart, W., Cella, D., Groopman, J.E., Homing, S.J., Itri, L.M., et al. (2000). Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition. Oncologist, 5, 353-360.
9. de Jong, N., Candel, M.J., Scheuten, H.C., Abu-Saad, H.H., & Courtens, A.M. (2004). Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy. Annals of Oncology, 15, 896-905.
10. de Jong, N., Courtens, A.M., Abu-Saad, H.H., & Schouten, H.C. (2002). Fatigue in patients with breast cancer receiving adjuvant chemotherapy: A review of the literature. Cancer Nursing, 25, 283-297.
11. Fairclough, D.L., Felting, J.H., Cella, D., Wonson, W., & Moinpour, C.M. (1999). Quality of life and quality adjusted survival for breast cancer patients receiving adjuvant therapy. Eastern Cooperative Oncology Group (ECOG). Quality of Life Research, 8, 723-731.
12. Green, D., Nail, L.M., Fieler, V.K., Dudgeon, D., & Jones, L.S. (1994). A comparison of patient-reported side effects among three chemotherapy regimens for breast cancer. Cancer Practice, 2, 57-62.
13. Hann, D.M., Garovoy, N., Finkelstein, B., Jacobsen, P.B., Azzarello, L.M., & Fields, K.K. (1999). Fatigue and quality of life in breast cancer patients undergoing autologous stem cell transplantation: A longitudinal comparative study. Journal of Pain and Symptom Management, 17, 311-319.
14. Hudis, C, & Norton, L. (2004). Evolving models in chemotherapy for breast cancer. Diseases of the Breast Updates, 7(4), 1-15.
15. Hwang, S.S., Chang, V.T., Rue, M., & Kasimis, B. (2003). Multidimensional independent predictors of cancer-related fatigue. Journal of Pain and Symptom Management, 26, 604-614.
16. Jacobsen, P.B., Hann, D.M., Azzarello, L.M., Horton, J., Balducci, L, & Lyman, G.H. (1999). Fatigue in women receiving adjuvant chemotherapy for breast cancer: Characteristics, course, and correlates. Journal of Pain and Symptom Management, 18, 233-242.
17. Kubista, E., Glaspy, J., Holmes, F.A., Green, M.D., Hackett, J., Neumann, T., et al. (2003). Bone pain associated with once-per-cycle pegfilgrastim is similar to daily filgrastim in patients with breast cancer. Clinical Breast Cancer, 3, 391-398.
18. Longman, A.J., Braden, C.J., & Mishel, M.H. (1997). Pattern of association over time of side-effects burden, self-help, and self-care in women with breast cancer. Oncology Nursing Forum, 24, 1555-1560.
19. Mast, M.E. (1998). Correlates of fatigue in survivors of breast cancer. Cancer Nursing, 21, 136-142.
20. Mock, V., Dow, K.H., Meares, C.J., Grimm, P.M., Dienemann, J.A., Haisfield-Wolfe, M.E., et al. (1997). Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncology Nursing Forum, 24, 991-1000.
21. National Comprehensive Cancer Network. (2003). Cancer-related fatigue: Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 1, 308-331.
22. Piper, B.F., Dibble, S.L., Dodd, M.J., Weiss, M.C., Slaughter, R.E., & Paul, S.M. (1998). The revised Piper Fatigue Scale: Psychometric evaluation in women with breast cancer. Oncology Nursing Forum, 25, 677-684.
23. Piper, B.F., Lindsey, A.M., & Dodd, M J. (1987). Fatigue mechanisms in cancer patients: Developing nursing theory. Oncology Nursing Forum, 14, 17-23.
24. Richardson, A., Ream, E., & Wilson-Barnett, J. (1998). Fatigue in patients receiving chemotherapy: Patterns of change. Cancer Nursing, 21, 17-30.
25. Schwanz, A.H. (2002). Validity of cancer-related fatigue instruments. Pharmacotherapy, 22, 1433-1441.
26. Stone, P., Richards, M., & Hardy, J. (1998). Fatigue in patients with cancer. European Journal of Cancer, 34, 1670-1676.
27. Tchen, N., Juffs, H.G., Downie, P.P., Yi, Q.L., Hu, H., Chemerynsky, I., et al. (2003). Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology, 21, 4175-4183.
28. von Minckwitz, G., Raab, G., Caputo, A., Schutte, M., Hilfrich, J., Blohmer, J., et al. (2005). Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: The GEPARDUO study of the German Breast Group. Journal of Clinical Oncology, 23, 2676-2685.
29. Woo, B., Dibble, S.L., Piper, B.R, Keating, S.B., & Weiss, M.C. (1998). Differences in fatigue by treatment methods in women with breast cancer. Oncology Nursing Forum, 25, 915-920.
30. Wu, H., & McSweeney, M. (2001). Measurement of fatigue in people with cancer. Oncology Nursing Forum, 28, 1371-1384.